Stemline Therapeutics Inc (NASDAQ:STML)

11.64
Delayed Data
As of Jul 02
 -0.18 / -1.52%
Today’s Change
10.50
Today|||52-Week Range
18.94
-31.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--2.0M2.8M25.0M
 
 
 
 
Short Term Investment Cash-1.4M-3.8M42.2M-19.2M
 
 
 
 
 
Cash & Short Term Investments28.4M2.0M44.2M54.0M
 
 
 
 
 
 
ReceivablesReceivables0.000.00199.6K0.00
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses------1.5M
 
 
Other Current Assets223.2K299.1K292.9K106.2K
 
 
 
 
 
Current Assets28.6M2.3M44.7M55.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross0.00--460.0K460.0K
 
 
 
Depreciation0.00---76.7K-230.0K
 
 
 
Other Assets400.0K2.7M0.000.00
 
 
 
Total Assets29.0M5.0M85.3M60.5M
 
 
 
 
 
 
LiabilitiesAccrued Expenses1.5M5.4M2.7M2.3M
 
 
 
 
 
Other Current Liabilities1.5M5.4M3.0M2.8M
 
 
 
 
 
Other Liabilities1.6M5.5M5.0M4.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt--2.0M0.000.00
 
 
Other Liabilities1.2M30.4K0.000.00
 
 
 
Total Liabilities2.8M7.5M5.7M5.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity26.2M-2.5M79.6M55.4M
 
 
 
 
 
Total Shareholder Equity26.2M-2.5M79.6M55.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding7.0M7.5M13.1M13.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account